OTCMKTS:CZMWY Carl Zeiss Meditec (CZMWY) Stock Forecast, Price & News $86.49 +1.14 (+1.33%) (As of 09/22/2023 08:53 PM ET) Add Compare Share Share Today's Range$85.69▼$87.2750-Day Range$85.35▼$115.6452-Week Range$84.91▼$153.84Volume10,500 shsAverage Volume2,633 shsMarket CapitalizationN/AP/E Ratio94.01Dividend Yield0.35%Price TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsDividendHeadlinesShort InterestProfileAnalyst RatingsChartCompetitorsDividendHeadlinesShort Interest Carl Zeiss Meditec MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestBearishDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.03 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Carl Zeiss Meditec. Previous Next 2.0 Short Interest Percentage of Shares ShortedShort Interest Ratio / Days to CoverCarl Zeiss Meditec has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Carl Zeiss Meditec has recently increased by 350.00%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend YieldCarl Zeiss Meditec pays a meaningful dividend of 1.36%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthCarl Zeiss Meditec does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Carl Zeiss Meditec is 32.64%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CZMWY. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for Carl Zeiss Meditec this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Carl Zeiss Meditec insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.10% of the stock of Carl Zeiss Meditec is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Carl Zeiss Meditec is 94.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 116.00.Price to Earnings Ratio vs. SectorThe P/E ratio of Carl Zeiss Meditec is 94.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 108.15. Previous Next See Top Rated MarketRank™ Stocks Here About Carl Zeiss Meditec (OTCMKTS:CZMWY) StockCarl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers offers products and solutions for the diagnosis and treatment of chronic eye diseases; and systems and consumables for refractive surgery. This segment also provides slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras used for the examination of the retina in hospitals and practices; and equipment for functional diagnostics. In addition, this segment offers surgical microscopes, biometers, and phacoemulsification or vitrectomy devices; and intraocular lenses for cataract patients. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.Read More CZMWY Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CZMWY Stock News HeadlinesSeptember 23, 2023 | fool.comCarl Zeiss Meditec Ag (ETR: AFX)September 23, 2023 | americanbankingnews.comContrasting Carl Zeiss Meditec (OTCMKTS:CZMWY) and Fisher & Paykel Healthcare (OTCMKTS:FSPKF)September 25, 2023 | Wall Street Fundamentals (Ad)Would Buffett Approve of This Growth Strategy?Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.September 17, 2023 | americanbankingnews.comCritical Comparison: Carl Zeiss Meditec (CZMWY) & The CompetitionSeptember 5, 2023 | finance.yahoo.comEstimating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)August 8, 2023 | msn.comCarl Zeiss Meditec: One Of The Highest Premiums I'll AcceptJuly 28, 2023 | seekingalpha.comCZMWF Carl Zeiss Meditec AGJuly 4, 2023 | finance.yahoo.comThere's Been No Shortage Of Growth Recently For Carl Zeiss Meditec's (ETR:AFX) Returns On CapitalSeptember 25, 2023 | Wall Street Fundamentals (Ad)Would Buffett Approve of This Growth Strategy?Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.June 16, 2023 | fool.comCarl Zeiss Meditec Ag (OTC: CZMWF)June 6, 2023 | finance.yahoo.comShould You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?April 12, 2023 | finance.yahoo.comInstitutions own 22% of Carl Zeiss Meditec AG (ETR:AFX) shares but private companies control 59% of the companyFebruary 19, 2023 | finance.yahoo.comCarl Zeiss Meditec First Quarter 2023 Earnings: Revenues Beat Expectations, EPS LagsFebruary 3, 2023 | markets.businessinsider.comEQS-AFR: Carl Zeiss Meditec AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statementsJanuary 20, 2023 | finance.yahoo.comCarl Zeiss Meditec (ETR:AFX) Is Increasing Its Dividend To €1.10January 12, 2023 | finance.yahoo.comCarl Zeiss Meditec (ETR:AFX) Might Have The Makings Of A Multi-BaggerDecember 28, 2022 | finance.yahoo.comCarl Zeiss Meditec AG's (ETR:AFX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?December 12, 2022 | finance.yahoo.comCarl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10December 9, 2022 | technews.tmcnet.comZEISS Academy Africa inauguratedNovember 12, 2022 | seekingalpha.comCZMWY Carl Zeiss Meditec AGMay 14, 2022 | markets.businessinsider.comWhat Wall Street expects from Carl Zeiss Meditec's earningsFebruary 13, 2022 | uk.finance.yahoo.comCarl Zeiss Meditec achieves further growth in first quarter of 2021/22February 13, 2022 | markets.businessinsider.comCarl Zeiss Meditec earnings preview: what Wall Street is expectingDecember 12, 2021 | uk.finance.yahoo.comRecord revenue for Carl Zeiss Meditec in fiscal year 2020/21December 10, 2021 | seekingalpha.comCarl Zeiss Meditec AG 2021 Q1 - Results - Earnings Call PresentationOctober 2, 2021 | uk.finance.yahoo.comChange to Executive Board of Carl Zeiss Meditec AGSeptember 30, 2021 | uk.finance.yahoo.comLeadership Change in the Executive Board of Carl Zeiss Meditec AGSee More Headlines Receive CZMWY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CZMWY CUSIPN/A CIKN/A Webwww.zeiss.com Phone493641220115FaxN/AEmployees4,224Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio94.01 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesDr. Markus WeberCEO & Chairman of Management BoardMr. Justus Felix Wehmer (Age 58)CFO & Member of the Management Board Comp: $635.31kMr. Sebastian FrericksDirector of Investor RelationsMr. Steven C. Schallhorn M.D.Chief Medical Officer for Global Ophthalmic DevicesMr. Andrew ChangHead of Sales for Ophthalmic Devices & Pres of Carl Zeiss Meditec, Inc.Dr. Euan S. Thomson Ph.D. (Age 60)Pres of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Bus. Unit Mr. Magnus ReibenspiessHead of the Microsurgery Strategic Bus. Unit - ZEISS Medical TechnologyDr. Christian Munster (Age 52)Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board More ExecutivesKey CompetitorsAddLife AB (publ)OTCMKTS:ADDLFAnsellOTCMKTS:ANSLYAnsellOTCMKTS:ANSLFAsahi InteccOTC:AHICFBATM Advanced CommunicationsOTCMKTS:BTAVFView All Competitors CZMWY Stock - Frequently Asked Questions Should I buy or sell Carl Zeiss Meditec stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CZMWY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CZMWY, but not buy additional shares or sell existing shares. View CZMWY analyst ratings or view top-rated stocks. How have CZMWY shares performed in 2023? Carl Zeiss Meditec's stock was trading at $126.09 on January 1st, 2023. Since then, CZMWY stock has decreased by 31.4% and is now trading at $86.4850. View the best growth stocks for 2023 here. Are investors shorting Carl Zeiss Meditec? Carl Zeiss Meditec saw a increase in short interest in August. As of August 31st, there was short interest totaling 1,800 shares, an increase of 350.0% from the August 15th total of 400 shares. Based on an average daily volume of 18,600 shares, the short-interest ratio is presently 0.1 days. View Carl Zeiss Meditec's Short Interest. How often does Carl Zeiss Meditec pay dividends? What is the dividend yield for Carl Zeiss Meditec? Carl Zeiss Meditec declared a dividend on Friday, March 17th. Stockholders of record on Friday, March 24th will be paid a dividend of $0.8144 per share on Tuesday, April 11th. This represents a dividend yield of 0.56%. The ex-dividend date is Thursday, March 23rd. This is a boost from the stock's previous dividend of $0.68. Read our dividend analysis for CZMWY. Is Carl Zeiss Meditec a good dividend stock? Carl Zeiss Meditec (OTCMKTS:CZMWY) pays an annual dividend of $0.30 per share and currently has a dividend yield of 1.36%. The dividend payout ratio is 32.64%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CZMWY. What is Carl Zeiss Meditec's stock symbol? Carl Zeiss Meditec trades on the OTCMKTS under the ticker symbol "CZMWY." How do I buy shares of Carl Zeiss Meditec? Shares of CZMWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Carl Zeiss Meditec's stock price today? One share of CZMWY stock can currently be purchased for approximately $86.49. How many employees does Carl Zeiss Meditec have? The company employs 4,224 workers across the globe. How can I contact Carl Zeiss Meditec? Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, Jena, Thueringen 07745. The official website for the company is www.zeiss.com. The company can be reached via phone at 493641220115. This page (OTCMKTS:CZMWY) was last updated on 9/25/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carl Zeiss Meditec AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.